Status:
UNKNOWN
Medicines Gaps Study
Lead Sponsor:
The Leeds Teaching Hospitals NHS Trust
Collaborating Sponsors:
Leeds Clinical Commissioning Group
Conditions:
Adherence, Medication
Statin Adverse Reaction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The adherence project aims to understand adherence rates and barriers to Direct oral anticoagulants (DOACs) and statins and improve awareness of healthcare professionals on adherence across Leeds. Du...
Eligibility Criteria
Inclusion
- adult patients
- having an active repeat prescription for a DOAC and/or a statin for at least 6 months prior to the date of data extraction
- a diagnosis of atrial fibrillation (AF) for those on a DOAC and of hypercholesterolemia for those on a statin (to justify the preventive nature of the treatments)
Exclusion
- Patients with an active repeat prescription for a DOAC and/or a statin for less than 6 months prior to the date of data extraction
Key Trial Info
Start Date :
May 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2022
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05332158
Start Date
May 30 2022
End Date
September 30 2022
Last Update
August 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds Teaching Hospitals Trust
Leeds, West Yorkshire, United Kingdom, LS1 3EX